Inclusion Criteria:  Patients treated with the Tendyne Mitral Valve System for mitral valve disease in a commercial setting Patients providing written informed consent in compliance with the protocol, the ICH-GCP and all national legal and regulatory requirements  Exclusion Criteria:  Patients not providing written informed consent